Founding Team Members

Kristina Zakurdaeva, MD, PhD

Chief Medical Officer of Gero, LLC
Founder & Chair of the Board of Directors

Alexei Marchenkov, PhD

Founder and CEO of Bleximo Corp.
Co-founder & Member of the Board of Directors

Ilya Tsimafeyeu, MD

Executive Director of the Russian Society of Clinical Oncology (RUSSCO), Director of Bureau for the Study of Kidney Cancer
Member of the Board of Directors

Anna Pilicheva, PhD, LL.M. (IP), LL.M.

Member of the Board of Directors

Board of Trustees

Boris Andrianov, Cellist

Instructor, Moscow State Tchaikovsky Conservatory, Honored Artist of Russia

Robert Peter Gale, MD, PhD, DSc (hon)

Visiting Professor of Hematology at the Imperial College of London, Executive Director of Clinical Research, Hematology and Oncology at Celgene Corp.

Rüdiger Hehlmann, o. Prof. Dr. med. Dr. h. c.

Founder and Chair of the European LeukemiaNet, Founder and Chair of the ELN Foundation

Stephen M. Sammut, МBA

Senior Fellow, Health Care Management and Lecturer, Entrepreneurship, Wharton School

Scientific Advisory Board

Sergey Tyulyandin, MD, DSci, Professor

Deputy Director and Head of Department of Clinical Pharmacology of N.N. Blokhin Russian Cancer Research Center (Moscow, Russia), Chair of the Russian Society of Clinical Oncology (RUSSCO)

Colin Begg, PhD

Chair, Department of Epidemiology & Biostatistics and Associate Director for Population Sciences, Memorial Sloan-Kettering Cancer Center (New York, USA)

Evgeny Imyanitov, DSci, Professor, Corresponding member of the Russian Academy of Sciences

Head of Department of Tumor Growth Biology of N.N. Petrov Institute of Oncology (St. Petersburg, Russia), Board member of the Russian Society of Clinical Oncology (RUSSCO)

Andrei Gudkov, DSci

Senior Vice President of Basic Science, Chair, Cell Stress Biology, The Garman Family Chair in Cell Stress Biology, Roswell Park Cancer Institute (Buffalo, USA)

Timur Mitin, MD, PhD

Assistant Professor at Oregon Health and Science University, Medical Director of the Tuality/OHSU Cancer Center (Portland, USA)

Hiltrud Brauch, PhD, Professor

Deputy Director, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and Head, Breast Cancer Susceptibility and Pharmacogenomics (Stuttgart, Germany)

Alexey Danilov, MD, PhD

Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA)

Tatiana Semiglazova, MD, DSci, Professor

Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov Russian Cancer Research Center (St. Petersburg, Russia), Professor, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia), Board member of the Russian Society of Clinical Oncology (RUSSCO)

Katerina Gurova, MD, PhD

Professor of Oncology, Department of Cell Stress Biology, Roswell Park Cancer Institute (Buffalo, USA)

Jacek Gronwald, PhD

Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland)

Nikolay Zhukov, DSci

Head of Department of Treatment Optimization of Adolescents, D. Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology (Moscow, Russia), Assistant Professor, Department of Oncology, Hematology and Radiotherapy, N.I. Pirogov Russian National Research Medical University (Moscow, Russia), Board member of the Russian Society of Clinical Oncology (RUSSCO)

Alexey Tryakin, MD, DSci

Head of Department of Сlinical Pharmacology and Сhemotherapy of the N.N.Blokhin Russian Cancer Research Center (Moscow, Russia), ESMO National Representative in the Russian Federation, Board member of the Russian Society of Clinical Oncology (RUSSCO)

Dmitry Nosov, MD, DSci, Professor

Head of the Department of the Oncology Department for Tumor Therapy, Central Clinical Hospital of the Presidential Administration of the Russian Federation (Moscow, Russia), Board member of the Russian Society of Clinical Oncology (RUSSCO)

Elena Artamonova, DSci

Principal Researcher, Department of Outpatient Chemotherapy of N.N. Blokhin Russian Cancer Research Center (Moscow, Russia), Board member of the Russian Society of Clinical Oncology (RUSSCO)

Irina Demidova, MD, PhD

Head of Molecular Diagnostic Laboratory, Moscow Oncological Hospital #62 (Russia)

Thilo Dörk, PhD

Head, Gynecology Research Unit, Clinics of Obstetrics and Gynecology, Hannover Medical School (Germany)

Zdenko Herceg, PhD

Head, Section of Mechanisms of Carcinogenesis & Head, Epigenetics Group International Agency for Research on Cancer (IARC-WHO)